Legal Representation
Attorney
KAVEH NEWMEN
USPTO Deadlines
Next Deadline
69 days remaining
Non-Final Action E-Mailed
Due Date
March 09, 2026
Extension Available
Until June 09, 2026
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 9, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 9, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 8, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 30, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 21, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 21, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Peptide substrates for scientific purposes
First Use Anywhere:
Jun 1, 2024
First Use in Commerce:
Jun 1, 2024
Class 005
Synthetic peptides for the treatment of of cellular aging and metabolic dysfunction; Synthetic peptides for the treatment of NAD+-deficiency related disorders
First Use Anywhere:
Jun 1, 2024
First Use in Commerce:
Jun 1, 2024
Additional Information
Pseudo Mark
SYNTHETIC NAD PLUS SYNTHETIC NICOTINAMIDE ADENINE DINUCLEOTIDE PLUS
Classification
International Classes
001
005